脊柱转移瘤多分次立体定向体部放疗的局部失败与椎体骨折风险
该回顾性分析纳入2009至2017年在本机构接受2至5次分次立体定向体部放疗(SBRT)的83例患者共98处脊柱转移病灶,中位随访7.6个月。6个月和1年局部控制率分别为93%和84%,椎体骨折(VBF)发生率为4.2%。多分次SBRT局部控制率高且VBF发生率低,提示较单次SBRT具有更有利的治疗比。
要点
- 83例患者98处脊柱转移灶接受中位24 Gy/3次的多分次SBRT,中位随访7.6个月。
- 6个月和1年局部控制率分别为93%和84%,VBF总发生率为4.2%。
- 仅既存VBF预测SBRT后VBF风险(P < .01),更高处方剂量和生物有效剂量等预测更优局部控制。
核心结论
- 多分次SBRT治疗脊柱转移瘤局部控制率高且VBF发生率低,提示较单次SBRT具有更有利的治疗比。
研究设计与样本
- 回顾性分析2009至2017年在本机构接受多分次SBRT的脊柱转移瘤患者,采用Cyberknife系统行2至5次分次照射。
- 共83例患者98处脊柱病灶,中位随访7.6个月,每3至6个月进行临床和磁共振成像随访。
主要发现
- 6个月局部控制率为93%,1年局部控制率为84%。
- VBF在所有病例中发生率为4.2%,在SBRT前未接受手术或椎体成形术的病例中为5.3%。
- 局部失败组与无失败组的累积剂量分别为23 Gy与26 Gy(P = .02),生物有效剂量分别为39 Gy与46 Gy(P = .01),90%计划靶区最低剂量分别为23 Gy与26 Gy(P = .03)。
- 仅既存VBF预测SBRT后VBF风险(P < .01)。
关键数值与推荐
- 更高处方剂量、更高生物有效剂量、更高90%计划靶区最低剂量、肿瘤组织学和更小肿瘤体积预测局部控制改善。
- 中位SBRT剂量为24 Gy,中位分次数为3次。
- 21%的病例在SBRT前接受了手术或椎体成形术。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Single-fraction radiation surgery for spine metastases is highly effective. However, a high rate (20-39%) of vertebral body fracture (VBF) has been associated with large, single-fraction doses. We report our experience using multifraction stereotactic body radiation therapy (SBRT). METHODS AND MATERIALS: All patients who were treated with multifraction SBRT for spine metastases at our institution between 2009 and 2017 were retrospectively analyzed. SBRT was delivered in 2 to 5 fractions using the Cyberknife System (Accuray, Sunnyvale, CA). Patients were followed clinically and with magnetic resonance imaging every 3 to 6 months. Local control, complications (including VBF), and overall survival were evaluated. Patient, disease, and treatment variables were analyzed for a statistical association with outcomes. RESULTS: A total of 83 patients were treated to 98 spine lesions with a median follow-up of 7.6 months. Histologies included non-small cell lung cancer (NSCLC; 24%), renal cell carcinoma (RCC; 18%), and breast cancer (12%). Surgery or vertebroplasty were performed before SBRT in 21% of cases. Patients received a median SBRT dose of 24 Gy in a median of 3 fractions. Local control was 93% at 6 months and 84% at 1 year. Higher prescribed dose, higher biologic effective dose, higher minimum dose to 90% of the planning target volume, tumor histology, and smaller tumor volume predicted improved local control. The cumulative dose was 23 Gy versus 26 Gy for patients with and without failure (P = .02), higher biologic effective dose 39 Gy versus 46 Gy, (P = .01), and higher minimum dose to 90% of the planning target volume 23 Gy versus 26 Gy (P = .03). VBF occurred in 4.2% of all cases and 5.3% of those without surgery or vertebroplasty prior to SBRT. Only preexisting VBF predicted risk of post-SBRT VBF (P < .01). CONCLUSIONS: Multifraction SBRT results in a high local control rate for metastatic spinal disease with a low VBF rate, which suggests a favorable therapeutic ratio compared with single-fraction SBRT.
引用
- Mehta N, Zavitsanos PJ, Moldovan K, et al. Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases. Adv Radiat Oncol. 2018. PMID: 30202794. doi:10.1016/j.adro.2018.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。